News & Updates

Tralokinumab a promising treatment option in young people with moderate-to-severe AD

29 Apr 2023

Targeting interleukin (IL)-13 with tralokinumab monotherapy helps reduce disease activity in adolescents with moderate-to-severe atopic dermatitis (AD) with a low frequency of conjunctivitis throughout the treatment period, according to data from the phase III ECZTRA 6 trial.

Tralokinumab a promising treatment option in young people with moderate-to-severe AD

29 Apr 2023

Adverse birth outcomes linked to heightened risk of AF up to middle age

28 Apr 2023

Individuals who were born preterm and large for gestational age are at increased risk of atrial fibrillation (AF) up to middle age, and the risk increase is independent of familial confounding factors, according to a multinational cohort study.

Adverse birth outcomes linked to heightened risk of AF up to middle age

28 Apr 2023

Larotrectinib reduces morbidity, need for aggressive therapies in children with IFS

28 Apr 2023 by

In the EPI-VITRAKVI study, the TRK* inhibitor larotrectinib reduces morbidity and the need for aggressive local therapies in children with infantile fibrosarcoma (IFS) compared with the current standard of care (SoC).

Larotrectinib reduces morbidity, need for aggressive therapies in children with IFS

28 Apr 2023

Psychological interventions can work wonders in children with PTSD

27 Apr 2023

Psychotherapies for children and adolescents with post-traumatic stress disorder (PTSD) appears to effectively induce response even in the context of multiple trauma exposure, such as abuse or maltreatment, according to the results of a systematic review and meta-analysis.

Psychological interventions can work wonders in children with PTSD

27 Apr 2023

Arcturus now on CDC watchlist

25 Apr 2023 by

A new coronavirus subvariant, “Arcturus,” has been making headlines in the US with the increased number of cases and no less than the US Centers for Disease Control and Prevention (CDC) has put it on its watch list.

Arcturus now on CDC watchlist

25 Apr 2023

HK doctors’ mental HRQoL significantly worse than the general population

25 Apr 2023 by

Doctors in Hong Kong have significantly poorer mental health-related quality of life (HRQoL) than the general population, with high rates of depression and burnout, a survey has shown.

HK doctors’ mental HRQoL significantly worse than the general population

25 Apr 2023

Nutritional supplementation promotes healthy weight gain in offspring

18 Apr 2023

Taking nutritional supplements before and throughout pregnancy puts children at lower risk of rapid weight gain and high body mass index, according to data from the NiPPeR trial.

Nutritional supplementation promotes healthy weight gain in offspring

18 Apr 2023

Scrotal US diagnosis testicular torsion has improved in past years: study

14 Apr 2023 by

The past 18 years in Singapore have seen an improvement in the diagnosis of testicular torsion with scrotal ultrasonography (US), which has demonstrated satisfactory results in sensitivity and negative predictive value over the past decades, according to a study.

Scrotal US diagnosis testicular torsion has improved in past years: study

14 Apr 2023

Early prostacyclin therapy beneficial to infants with congenital diaphragmatic hernia

13 Apr 2023

In neonates with congenital diaphragmatic hernia, early treatment with prostacyclin appears to reduce the need for extracorporeal life support in the postnatal period, according to a study.

Early prostacyclin therapy beneficial to infants with congenital diaphragmatic hernia

13 Apr 2023

Lebrikizumab helps clear skin of teens with moderate-to-severe atopic dermatitis

12 Apr 2023 by

Treatment with lebrikizumab with or without topical corticosteroids (TCS) results in clinical improvement among adolescents with moderate-to-severe atopic dermatitis (AD), according to a study presented at the recent AAD 2023.

Lebrikizumab helps clear skin of teens with moderate-to-severe atopic dermatitis

12 Apr 2023

News & Updates

Filter by Specialty:

Specialty:

Tralokinumab a promising treatment option in young people with moderate-to-severe AD

Tralokinumab a promising treatment option in young people with moderate-to-severe AD

Adverse birth outcomes linked to heightened risk of AF up to middle age

Adverse birth outcomes linked to heightened risk of AF up to middle age

Larotrectinib reduces morbidity, need for aggressive therapies in children with IFS

Larotrectinib reduces morbidity, need for aggressive therapies in children with IFS

Psychological interventions can work wonders in children with PTSD

Psychological interventions can work wonders in children with PTSD

Arcturus now on CDC watchlist

Arcturus now on CDC watchlist

HK doctors’ mental HRQoL significantly worse than the general population

HK doctors’ mental HRQoL significantly worse than the general population

Nutritional supplementation promotes healthy weight gain in offspring

Nutritional supplementation promotes healthy weight gain in offspring

Scrotal US diagnosis testicular torsion has improved in past years: study

Scrotal US diagnosis testicular torsion has improved in past years: study

Early prostacyclin therapy beneficial to infants with congenital diaphragmatic hernia

Early prostacyclin therapy beneficial to infants with congenital diaphragmatic hernia

Lebrikizumab helps clear skin of teens with moderate-to-severe atopic dermatitis

Lebrikizumab helps clear skin of teens with moderate-to-severe atopic dermatitis